-
Je něco špatně v tomto záznamu ?
Signs of Deregulated Gene Expression Are Present in Both CD14+ and CD14- PBMC From Non-Obese Men With Family History of T2DM
M. Koc, M. Šiklová, V. Šrámková, M. Štěpán, E. Krauzová, V. Štich, L. Rossmeislová
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- biologické markery metabolismus MeSH
- diabetes mellitus 2. typu genetika metabolismus patologie MeSH
- dospělí MeSH
- genetická predispozice k nemoci * MeSH
- glukózový toleranční test MeSH
- krevní glukóza analýza MeSH
- leukocyty mononukleární metabolismus patologie MeSH
- lidé MeSH
- lipopolysacharidové receptory metabolismus MeSH
- regulace genové exprese * MeSH
- studie případů a kontrol MeSH
- transkriptom * MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Aim: Development of type 2 diabetes (T2DM) is associated with disturbances in immune and metabolic status that may be reflected by an altered gene expression profile of peripheral blood mononuclear cells (PBMC). To reveal a potential family predisposition to these alterations, we investigated the regulation of gene expression profiles in circulating CD14+ and CD14- PBMC in fasting conditions and in response to oral glucose tolerance test (OGTT) in glucose tolerant first-degree relatives (FDR) of T2DM patients and in control subjects. Materials and Methods: This work is based on the clinical study LIMEX (NCT03155412). Non-obese 12 non-diabetic (FDR), and 12 control men without family history of diabetes matched for age and BMI underwent OGTT. Blood samples taken before and at the end of OGTT were used for isolation of circulating CD14+ and CD14- PBMC. In these cells, mRNA levels of 94 genes related to lipid and carbohydrate metabolism, immunity, and inflammation were assessed by qPCR. Results: Irrespectively of the group, the majority of analyzed genes had different mRNA expression in CD14+ PBMC compared to CD14- PBMC in the basal (fasting) condition. Seven genes (IRS1, TLR2, TNFα in CD14+ PBMC; ABCA1, ACOX1, ATGL, IL6 in CD14- PBMC) had different expression in control vs. FDR groups. OGTT regulated mRNA levels of nine genes selectively in CD14+ PBMC and of two genes (ABCA1, PFKL) selectively in CD14-PBMC. Differences in OGTT-induced response between FDR and controls were observed for EGR2, CCL2 in CD14+ PBMC and for ABCA1, ACOX1, DGAT2, MLCYD, and PTGS2 in CD14- PBMC. Conclusion: This study revealed a different impact of glucose challenge on gene expression in CD14+ when compared with CD14- PBMC fractions and suggested possible impact of family predisposition to T2DM on basal and OGTT-induced gene expression in these PBMC fractions. Future studies on these putative alterations of inflammation and lipid metabolism in fractionated PBMC in larger groups of subjects are warranted.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019240
- 003
- CZ-PrNML
- 005
- 20210830100822.0
- 007
- ta
- 008
- 210728s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2020.582732 $2 doi
- 035 __
- $a (PubMed)33658980
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Koc, Michal $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia
- 245 10
- $a Signs of Deregulated Gene Expression Are Present in Both CD14+ and CD14- PBMC From Non-Obese Men With Family History of T2DM / $c M. Koc, M. Šiklová, V. Šrámková, M. Štěpán, E. Krauzová, V. Štich, L. Rossmeislová
- 520 9_
- $a Aim: Development of type 2 diabetes (T2DM) is associated with disturbances in immune and metabolic status that may be reflected by an altered gene expression profile of peripheral blood mononuclear cells (PBMC). To reveal a potential family predisposition to these alterations, we investigated the regulation of gene expression profiles in circulating CD14+ and CD14- PBMC in fasting conditions and in response to oral glucose tolerance test (OGTT) in glucose tolerant first-degree relatives (FDR) of T2DM patients and in control subjects. Materials and Methods: This work is based on the clinical study LIMEX (NCT03155412). Non-obese 12 non-diabetic (FDR), and 12 control men without family history of diabetes matched for age and BMI underwent OGTT. Blood samples taken before and at the end of OGTT were used for isolation of circulating CD14+ and CD14- PBMC. In these cells, mRNA levels of 94 genes related to lipid and carbohydrate metabolism, immunity, and inflammation were assessed by qPCR. Results: Irrespectively of the group, the majority of analyzed genes had different mRNA expression in CD14+ PBMC compared to CD14- PBMC in the basal (fasting) condition. Seven genes (IRS1, TLR2, TNFα in CD14+ PBMC; ABCA1, ACOX1, ATGL, IL6 in CD14- PBMC) had different expression in control vs. FDR groups. OGTT regulated mRNA levels of nine genes selectively in CD14+ PBMC and of two genes (ABCA1, PFKL) selectively in CD14-PBMC. Differences in OGTT-induced response between FDR and controls were observed for EGR2, CCL2 in CD14+ PBMC and for ABCA1, ACOX1, DGAT2, MLCYD, and PTGS2 in CD14- PBMC. Conclusion: This study revealed a different impact of glucose challenge on gene expression in CD14+ when compared with CD14- PBMC fractions and suggested possible impact of family predisposition to T2DM on basal and OGTT-induced gene expression in these PBMC fractions. Future studies on these putative alterations of inflammation and lipid metabolism in fractionated PBMC in larger groups of subjects are warranted.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a diabetes mellitus 2. typu $x genetika $x metabolismus $x patologie $7 D003924
- 650 12
- $a regulace genové exprese $7 D005786
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a glukózový toleranční test $7 D005951
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukocyty mononukleární $x metabolismus $x patologie $7 D007963
- 650 _2
- $a lipopolysacharidové receptory $x metabolismus $7 D018950
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šiklová, Michaela $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France
- 700 1_
- $a Šrámková, Veronika $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France
- 700 1_
- $a Štěpán, Marek $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Department of Internal Medicine, Third Faculty of Medicine, Charles University, and Kralovske Vinohrady University Hospital, Prague, Czechia
- 700 1_
- $a Krauzová, Eva $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Department of Internal Medicine, Third Faculty of Medicine, Charles University, and Kralovske Vinohrady University Hospital, Prague, Czechia
- 700 1_
- $a Štich, Vladimír $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France $u Department of Internal Medicine, Third Faculty of Medicine, Charles University, and Kralovske Vinohrady University Hospital, Prague, Czechia
- 700 1_
- $a Rossmeislová, Lenka $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 11, č. - (2020), s. 582732
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33658980 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100823 $b ABA008
- 999 __
- $a ok $b bmc $g 1690135 $s 1139686
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 11 $c - $d 582732 $e 20210215 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
- LZP __
- $a Pubmed-20210728